Feasibility of Combination Intra-arterial Yttrium-90 and Irinotecan Microspheres in the VX2 Rabbit Model
Sign Up to like & getrecommendations! Published in 2020 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02538-x
Abstract: Purpose To evaluate the combination of 90 Y radioembolization (Y90) and drug-eluting bead irinotecan (DEBIRI) microspheres in the VX2 rabbit model. Materials and Methods An initial dose finding study was performed in 6 White New… read more here.
Keywords: control; treatment; debiri; rabbit ... See more keywords
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Cancer"
DOI: 10.1038/s41416-020-0917-4
Abstract: Background Chemo-embolisation with drug-eluting beads loaded with irinotecan (DEBIRI) increased survival as compared with intravenous irinotecan in chemorefractory patients with liver-dominant metastases from colorectal cancer (LMCRC). First-line DEBIRI with systemic chemotherapy may increase survival and… read more here.
Keywords: metastases colorectal; debiri; irinotecan debiri; cancer ... See more keywords
DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Future oncology"
DOI: 10.2217/fon-2017-0025
Abstract: AIM This single institution Phase II study evaluated drug-eluting beads loaded with irinotecan (DEBIRI) plus capecitabine in pretreated patients with colorectal cancer liver metastases. PATIENTS & METHODS Forty patients with liver-limited or liver-dominant disease, who… read more here.
Keywords: plus capecitabine; colorectal cancer; liver; debiri ... See more keywords